{{Rsnum
|rsid=2179652
|Gene=LOC100130137
|Chromosome=1
|position=192800696
|Orientation=plus
|GMAF=0.4279
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 21.5 | 47.7 | 30.8
| HCB | 4.4 | 57.8 | 37.8
| JPT | 11.4 | 34.1 | 54.5
| YRI | 20.6 | 38.1 | 41.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.4 | 57.8 | 37.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=18347610
|Title=Further evidence for association of the [[RGS2]] gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region
}}

{{PMID Auto
|PMID=18262772
|Title=Association of RGS2 and RGS5 variants with schizophrenia symptom severity.
|OA=1
}}

{{PMID Auto
|PMID=20386734
|Title=Further evidence supporting a role for gs signal transduction in severe malaria pathogenesis.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}